Abstract
The introduction of each vaccination brings many new problems as well as questions. The article summarizes the data from the most recent versions of the summaries of product characteristics (SPC) both registered with us rotavirus vaccines.
Are discussed first experience with vaccination and strategies of preventive measures elsewhere in the world.